ZBIO
Zenas BioPharma, Inc.
28.20$
+4.6%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63.7% | – | – | – | – | -771.1% | -370.5% | – | – | -524.1% | – | -5,723.7% | -2,054.3% | |
| 0.1% | – | – | – | – | 0.7% | 0.2% | – | – | -0.3% | – | 0.4% | -1.1% | |
| 2.0% | – | – | – | – | 109.9% | 53.9% | – | – | 75.8% | – | 861.9% | 297.5% | |
| -9.9% | – | – | – | – | 177.3% | -88.6% | – | – | 83.1% | – | 877.7% | 32.4% | |
| 0.0% | – | – | – | – | 1.5% | 0.2% | – | – | 300.0% | – | 3,000.0% | 590.9% | |
| – | – | – | – | – | -74.7% | -862.7% | – | – | -933.6% | – | -28,770.4% | -2,812.9% | |
| – | – | – | – | – | 0.0% | 0.0% | – | – | – | – | 2,910.0% | – | |
| 40.0% | – | – | – | – | 37.1% | 1.0% | – | – | 1,408.4% | – | 4,205.7% | 6,263.6% | |
| 103.7% | – | – | – | – | -805.9% | -1,232.8% | – | – | -49.2% | – | -30,364.7% | 1,387.0% | |
| 63.7% | – | – | – | – | -772.6% | -370.7% | – | – | -524.1% | – | -5,723.7% | -2,054.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.